An innovative $180M cancer treatment system that was moving from a R&D system into a full-fledged production end-item. The 2000+ activity schedule was critical to identifying key procurement dates for long lead items being purchased globally. The complex schedule aided Optivus in systematizing a project that included constructing a new test facility, a new hospital wing for the Conforma 3000, and the cancer treatment system itself.